C-reactive protein (CRP) is produced by the liver in response to inflammation, signaling potential health issues.

Cite this: C-Reactive Protein: A Guideline for Its Application - Medscape - Mar 01, 2003. Tables. References. Authors and Disclosures. Authors and Disclosures. Ezra A. Amsterdam, MD, Editor in Chief ...

C-reactive protein and response to adalimumab in patients with hidradenitis suppurativa: a post hoc analysis of 2 randomized clinical trials. JAMA Dermatol . Published online January 8, 2025. doi ...

C-reactive protein (CRP) is a commonly used marker of inflammation, and inflammatory disease is suspected when CRP levels exceed 10 mg/L. Researchers are unclear whether and to what extent ...

C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes, International Journal of Cardiology, 152, 1, (7-12), (2011 ...

C-reactive protein and coronary artery calcification are two non-traditional risk factors that may improve the power to predict coronary heart disease. Is it time to recalibrate Framingham scores?

C-reactive protein (CRP) is a highly conserved plasma protein that plays a role in the systemic response to inflammation. 5 This protein is produced in the liver and released by hepatocytes in ...

Measures of inflammation—and C-reactive protein (CRP), in particular—appear to be valuable prognostic tools for patients with intrahepatic cholangiocarcinoma (ICC) who are receiving anti ...

Overall, oral nonsteroidal anti-inflammatory drugs (NSAIDs) do not have an effect on C-reactive protein (CRP) levels in patients with rheumatoid arthritis (RA).

The presence of calcium in coronary arteries is a much better predictor of heart attack and stroke than C-reactive protein among people with normal levels of LDL cholesterol, according to a study ...